Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
002412 Hunan Hansen Pharmaceutical
- 6.36
- +0.10+1.60%
Market Closed Dec 20 15:00 CST
3.20BMarket Cap14.16P/E (TTM)
6.42High6.25Low81.61KlotVolume6.26Open6.26Pre Close51.57MTurnover1.64%Turnover Ratio15.63P/E (Static)503.20MShares7.0752wk High1.52P/B3.17BFloat Cap4.0852wk Low6.89Limit Up497.85MShs Float23.15Historical High5.63Limit Down2.72%Amplitude3.36Historical Low--Dividend TTM6.32Avg Price35.96KlotAsk--Div YieldTTM100Lot Size45.44KlotBid
Hunan Hansen Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -5.65%61.9M | 0.75%109.91M | -48.04%74.79M | -64.84%51.13M | -55.69%65.6M | -6.18%109.1M | 58.61%143.95M | 61.00%145.41M | 17.47%148.06M | -36.05%116.28M |
| Transactional financial assets | 92.93%308.93M | 116.50%215.6M | -0.84%199.03M | 50.10%203.87M | 52.01%160.12M | 105.45%99.58M | 400.73%200.72M | 175.84%135.82M | --105.34M | --48.47M |
| Notes receivable and accounts receivable | 17.79%331.27M | 24.23%356.78M | 24.63%350.55M | 9.68%303.02M | -3.89%281.25M | -6.76%287.2M | -2.77%281.26M | 9.74%276.27M | 25.46%292.64M | 6.80%308.01M |
| -Notes receivable | -20.81%36.2M | -14.50%35.78M | -12.10%37.4M | -0.57%43.84M | -5.88%45.72M | -27.99%41.85M | -3.20%42.55M | -0.59%44.09M | 83.47%48.57M | -19.01%58.12M |
| -Accounts receivable | 25.28%295.07M | 30.83%320.99M | 31.18%313.14M | 11.63%259.18M | -3.50%235.53M | -1.82%245.35M | -2.70%238.71M | 11.95%232.18M | 18.03%244.07M | 15.35%249.89M |
| Other receivables (including interest and dividends) | -48.91%6.61M | -57.23%6.98M | -61.72%6.44M | -30.25%8.34M | 284.79%12.95M | 802.15%16.32M | 928.93%16.82M | 543.42%11.96M | -93.39%3.36M | -93.00%1.81M |
| -Other receivable | ---- | -57.23%6.98M | ---- | ---- | ---- | 802.15%16.32M | ---- | 543.42%11.96M | ---- | -93.00%1.81M |
| Advance payment | -22.21%3.66M | 82.32%4.71M | -10.45%3.5M | -30.29%2.94M | -5.88%4.7M | -75.40%2.58M | -41.45%3.9M | -27.18%4.22M | 177.34%4.99M | 1,281.45%10.5M |
| Inventories | -8.15%221.55M | -6.88%221.1M | -8.23%220.52M | -6.28%231.12M | 124.77%241.21M | 130.85%237.45M | 155.32%240.31M | 138.57%246.62M | 18.41%107.31M | 16.12%102.86M |
| Receivable financing | -14.32%37.72M | -20.49%35.71M | -9.58%41.67M | 11.74%49.5M | 16.43%44.02M | 37.64%44.91M | 96.77%46.08M | 109.72%44.3M | --37.81M | --32.63M |
| Other current assets | 234.77%68.49M | 247.22%67.32M | 18,091.23%51.89M | 5,585.28%46.15M | 73.74%20.46M | 3,508.72%19.39M | -98.06%285.26K | -93.21%811.72K | -83.84%11.78M | -95.61%537.23K |
| Total current assets | 25.27%1.04B | 24.69%1.02B | 1.61%948.38M | 3.54%896.07M | 16.73%830.31M | 31.46%816.53M | 66.48%933.34M | 61.63%865.4M | 23.60%711.3M | 3.92%621.1M |
| Non Current assets | ||||||||||
| Investment real estate | -6.97%3.43M | -6.85%3.49M | -6.74%3.55M | -6.63%3.62M | -6.52%3.68M | 20.10%3.75M | 20.23%3.81M | 20.36%3.87M | 22.35%3.94M | -6.03%3.12M |
| Long-term equity investment | 2.52%838.58M | 2.60%852.91M | 6.59%851.94M | 7.74%841.81M | 5.36%817.98M | 12.94%831.26M | 11.71%799.24M | 10.37%781.35M | 12.42%776.39M | 11.63%736.03M |
| Fixed assets | ---- | 17.78%480.13M | ---- | ---- | ---- | -9.07%407.66M | ---- | -7.12%425.65M | ---- | -0.87%448.34M |
| Constru in process | ---- | 90.78%12.44M | ---- | ---- | ---- | 22.07%6.52M | ---- | 15.70%6.09M | ---- | -70.30%5.34M |
| Productive biological assets | 9.14%9.31M | 10.57%9.15M | 13.14%8.7M | 12.39%8.66M | 14.00%8.53M | 12.90%8.28M | 6.50%7.69M | 7.15%7.71M | 5.73%7.49M | 6.20%7.33M |
| Intangible assets | -3.83%29.49M | -5.69%29.91M | -9.34%29.22M | -12.39%29.54M | -12.85%30.67M | -15.76%31.72M | -19.67%32.23M | -20.81%33.72M | -21.87%35.19M | -20.68%37.65M |
| Goodwill | 0.00%14.79M | 0.00%14.79M | 0.00%14.79M | 0.00%14.79M | -72.11%14.79M | -72.11%14.79M | -72.11%14.79M | -72.11%14.79M | -42.77%53.03M | -42.77%53.03M |
| Long deferred expense | -4.70%14.59M | -4.64%14.77M | -4.24%14.95M | -3.73%15.13M | -3.67%15.31M | -3.62%15.49M | -3.92%15.61M | -4.34%15.71M | -4.29%15.89M | -4.25%16.07M |
| Deferred tax assets | 32.85%2.47M | 33.16%2.55M | 21.33%2.4M | 22.05%2.5M | -2.35%1.86M | -2.49%1.92M | -3.59%1.98M | -3.11%2.04M | -11.32%1.91M | -12.11%1.97M |
| Other non current assets | -89.12%15.04M | -89.35%14.99M | -88.21%16.1M | -87.06%17.42M | -49.67%138.15M | -48.62%140.77M | -51.40%136.51M | -51.90%134.6M | 89.71%274.51M | 93.89%274.01M |
| Total non current assets | -1.87%1.41B | -1.85%1.44B | 0.45%1.44B | 1.04%1.44B | -10.90%1.44B | -7.63%1.46B | -8.68%1.44B | -9.54%1.43B | 10.01%1.62B | 9.90%1.58B |
| Total assets | 8.06%2.45B | 7.66%2.45B | 0.91%2.39B | 1.99%2.34B | -2.45%2.27B | 3.39%2.28B | 11.08%2.37B | 8.51%2.29B | 13.84%2.33B | 8.15%2.2B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -11.44%79.8M | -30.44%90.51M | -20.83%95.12M | -20.83%95.12M | -39.99%90.11M | 25.76%130.13M | 16.76%120.15M | -8.83%120.15M | -15.64%150.16M | -52.53%103.47M |
| Notes payable and accounts payable | -19.79%23.34M | 0.46%30.03M | -14.70%29.22M | -5.79%41.11M | -22.85%29.1M | -25.62%29.89M | 1.64%34.25M | -15.18%43.63M | 15.30%37.72M | -0.44%40.18M |
| -Accounts payable | -19.79%23.34M | 0.46%30.03M | -14.70%29.22M | -5.79%41.11M | -22.85%29.1M | -25.62%29.89M | 1.64%34.25M | -15.18%43.63M | 15.30%37.72M | -0.44%40.18M |
| Contract liabilities | -24.43%791.34K | -39.96%844.55K | -38.71%1.07M | -7.73%6.48M | -0.79%1.05M | 36.63%1.41M | 8.56%1.75M | 309.33%7.02M | -14.11%1.06M | -75.20%1.03M |
| Salaries payable | -26.57%17.59M | -25.38%17.74M | -22.94%17.98M | 10.40%45.42M | 6.73%23.95M | 8.42%23.77M | 8.72%23.33M | -7.09%41.14M | -6.50%22.44M | 0.51%21.92M |
| Taxs payable | 78.07%6.26M | 90.83%9.34M | -36.72%11.74M | -12.80%13.93M | -64.16%3.52M | -76.51%4.89M | 7.58%18.56M | 82.68%15.97M | 164.88%9.81M | 90.81%20.83M |
| Other payable (including interest and dividends) | -19.59%182.02M | -3.07%197.02M | 5.51%182.94M | 4.13%138.09M | 18.50%226.35M | 41.73%203.27M | 46.08%173.39M | 51.18%132.6M | 174.00%191.02M | 144.94%143.42M |
| -Other payable | ---- | -3.07%197.02M | ---- | ---- | ---- | 41.73%203.27M | ---- | 51.18%132.6M | ---- | 145.90%143.42M |
| Other current liabilities | 12.60%15.66M | -58.81%8.99M | -80.77%4.53M | -22.46%15.29M | -48.58%13.91M | -36.02%21.83M | -16.54%23.56M | -22.44%19.72M | 16,846.23%27.05M | 6,223.81%34.12M |
| Total current liabilities | -16.11%325.46M | -14.62%354.47M | -13.26%342.6M | -6.53%355.42M | -11.67%387.99M | 13.76%415.19M | 21.97%394.99M | 8.30%380.24M | 41.91%439.26M | 3.01%364.98M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | -14.77%983.19K | -18.25%1M | -22.48%1.05M | -20.63%1.22M | 7.49%1.15M | 0.34%1.23M | -0.40%1.36M | -7.09%1.54M | -40.07%1.07M | -38.26%1.23M |
| Long term deferred income | 52.15%24.97M | 18.96%20.16M | 9.03%19.07M | 11.83%16.81M | 11.90%16.41M | 11.64%16.95M | 11.40%17.49M | -7.32%15.03M | -11.54%14.67M | -11.16%15.18M |
| Total non current liabilities | 47.75%25.95M | 16.44%21.17M | 6.76%20.12M | 8.81%18.04M | 11.59%17.56M | 10.79%18.18M | 10.46%18.85M | -7.30%16.58M | -14.32%15.74M | -13.98%16.41M |
| Total liabilities | -13.35%351.41M | -13.32%375.64M | -12.35%362.72M | -5.89%373.46M | -10.87%405.55M | 13.63%433.37M | 21.39%413.83M | 7.54%396.81M | 38.76%455M | 2.14%381.39M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M | 0.00%503.2M |
| Capital reserve funds | 0.00%234.12M | 0.00%234.12M | 0.00%234.12M | 0.00%234.12M | 14.95%234.12M | 15.72%234.12M | 15.72%234.12M | 0.58%234.12M | 0.67%203.66M | 0.00%202.31M |
| Surplus reserve funds | 11.50%175.82M | 11.50%175.82M | 11.50%175.82M | 11.50%175.82M | 14.04%157.69M | 14.04%157.69M | 14.04%157.69M | 14.71%157.69M | 12.50%138.28M | 12.50%138.28M |
| Retained profit | 21.60%1.17B | 20.85%1.14B | 3.70%1.1B | 3.58%1.04B | -5.27%962.4M | -2.22%943.33M | 12.90%1.06B | 17.21%1B | 14.35%1.02B | 14.09%964.75M |
| Other composite income | 163.13%17.83M | 250.30%24.41M | 1,409.12%16.48M | 329.86%10.34M | -36.74%6.78M | -50.37%6.97M | -89.07%1.09M | -135.64%-4.5M | 1,364.65%10.71M | 248.04%14.04M |
| Shareholders equity without minority interests | 12.72%2.1B | 12.59%2.08B | 3.72%2.03B | 3.64%1.96B | -0.41%1.86B | 1.25%1.85B | 9.12%1.95B | 8.71%1.89B | 9.08%1.87B | 9.50%1.82B |
| Total shareholder equity | 12.72%2.1B | 12.59%2.08B | 3.72%2.03B | 3.64%1.96B | -0.41%1.86B | 1.25%1.85B | 9.12%1.95B | 8.71%1.89B | 9.08%1.87B | 9.50%1.82B |
| Total liabilityies and equity | 8.06%2.45B | 7.66%2.45B | 0.91%2.39B | 1.99%2.34B | -2.45%2.27B | 3.39%2.28B | 11.08%2.37B | 8.51%2.29B | 13.84%2.33B | 8.15%2.2B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
